Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The rates of respiratory syncytial virus-associated hospitalizations were three to nine times higher for assisted living residents compared with the rates for community-dwelling older adults in a ...

Most people notice this when air pressure changes rapidly, such as when a plane ascends or descends. This happens because the pressurization of the cabin isn't perfect, and the ear pressure is higher ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...